Legato Capital Management LLC Has $1.25 Million Stock Position in CVS Health Co. (NYSE:CVS)

Legato Capital Management LLC increased its position in shares of CVS Health Co. (NYSE:CVS) by 9.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,914 shares of the pharmacy operator’s stock after acquiring an additional 2,470 shares during the period. Legato Capital Management LLC’s holdings in CVS Health were worth $1,253,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently modified their holdings of the company. Kentucky Trust Co bought a new stake in shares of CVS Health during the 4th quarter valued at approximately $696,000. Polaris Capital Management LLC lifted its stake in CVS Health by 7.6% in the 4th quarter. Polaris Capital Management LLC now owns 489,500 shares of the pharmacy operator’s stock valued at $21,974,000 after purchasing an additional 34,700 shares during the last quarter. Stonebridge Financial Group LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $28,000. Bristlecone Advisors LLC grew its stake in shares of CVS Health by 4.3% during the fourth quarter. Bristlecone Advisors LLC now owns 10,788 shares of the pharmacy operator’s stock worth $484,000 after buying an additional 448 shares during the last quarter. Finally, Newbridge Financial Services Group Inc. bought a new position in shares of CVS Health in the 4th quarter valued at $111,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS opened at $63.23 on Thursday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a fifty day moving average of $50.61 and a 200-day moving average of $55.92. The firm has a market capitalization of $79.57 billion, a P/E ratio of 16.05, a P/E/G ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, sell-side analysts anticipate that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.21%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on CVS shares. UBS Group reduced their price objective on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday. Truist Financial reduced their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Piper Sandler cut their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Finally, Wolfe Research raised their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $67.78.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.